Broadwood Capital Inc., 10% Owner at Oncocyte Corp (OCX), bought 2,630,678 shares at $2.95 ($7.8M) on 2024-10-02, disclosed to the SEC on 2024-10-04.
Open-market purchase of $7.8M OCX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.95 | 1,315,339 | $3.9M | 50.0% |
| 2 | $2.95 | 1,315,339 | $3.9M | 50.0% |
| Total | $2.95 avg | 2,630,678 | $7.8M | 100% |
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |